{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:00:21Z","timestamp":1780732821587,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-026-04813-y","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:24:07Z","timestamp":1780730647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrawound vancomycin powder for infection prophylaxis in definitive fixation of complex fractures: a systematic review and meta-analysis of efficacy and safety"],"prefix":"10.1007","volume":"36","author":[{"given":"Diana","family":"Sarmiento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Guio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime A.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"4","key":"4813_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.JAA.0000531052.82007.42","volume":"31","author":"RA Borchardt","year":"2018","unstructured":"Borchardt RA, Tzizik D (2018) Update on surgical site infections: the new CDC guidelines. JAAPA 31(4):52\u201354. https:\/\/doi.org\/10.1097\/01.JAA.0000531052.82007.42. (PubMed PMID: 30973535)","journal-title":"JAAPA"},{"issue":"3","key":"4813_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.injury.2017.08.040","volume":"49","author":"WJ Metsemakers","year":"2018","unstructured":"Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M et al (2018) Fracture-related infection: a consensus on definition from an international expert group. Injury 49(3):505\u2013510. https:\/\/doi.org\/10.1016\/j.injury.2017.08.040. (PubMed PMID: 28867644)","journal-title":"Injury"},{"issue":"4","key":"4813_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.injury.2023.01.055","volume":"54","author":"H Wang","year":"2023","unstructured":"Wang H, Liu Y, Shi Z, Wang D, Zhang H, Diao S et al (2023) Intrawound application of vancomycin reduces the proportion of fracture-related infections in high-risk tibial plateau fractures. Injury 54(4):1088\u20131094. https:\/\/doi.org\/10.1016\/j.injury.2023.01.055. (PubMed PMID: 36740472)","journal-title":"Injury"},{"issue":"1","key":"4813_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.recot.2023.07.002","volume":"68","author":"A Coelho","year":"2024","unstructured":"Coelho A, Par\u00e9s-Alfonso I, Companys R, S\u00e1nchez-Soler JF, Torres-Claramunt R, Alier A et al (2024) Factores de riesgo de infecci\u00f3n de fracturas de meseta tibial. Rev Esp Cir Ortop Traumatol 68(1):44\u201349. https:\/\/doi.org\/10.1016\/j.recot.2023.07.002","journal-title":"Rev Esp Cir Ortop Traumatol"},{"issue":"2","key":"4813_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.22038\/abjs.2021.53590.2665","volume":"10","author":"O O\u2019Connor","year":"2022","unstructured":"O\u2019Connor O, Thahir A, Krkovic M (2022) How much does an infected fracture cost? Arch Bone Jt Surg 10(2):135\u2013140. https:\/\/doi.org\/10.22038\/abjs.2021.53590.2665","journal-title":"Arch Bone Jt Surg"},{"issue":"4","key":"4813_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jcot.2015.04.004","volume":"6","author":"RV Thakore","year":"2015","unstructured":"Thakore RV, Greenberg SE, Shi H, Foxx AM, Francois EL, Prablek MA et al (2015) Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost. J Clin Orthop Trauma 6(4):220\u2013226. https:\/\/doi.org\/10.1016\/j.jcot.2015.04.004","journal-title":"J Clin Orthop Trauma"},{"issue":"5","key":"4813_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/ice.2023.67","volume":"44","author":"MS Calderwood","year":"2023","unstructured":"Calderwood MS, Anderson DJ, Bratzler DW, Dellinger EP, Garcia-Houchins S, Maragakis LL et al (2023) Strategies to prevent surgical site infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 44(5):695\u2013720. https:\/\/doi.org\/10.1017\/ice.2023.67. (PubMed PMID: 37137483)","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"24","key":"4813_CR8","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","volume":"36","author":"FA Sweet","year":"2011","unstructured":"Sweet FA, Roh M, Sliva C (2011) Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine 36(24):2084\u20132088. https:\/\/doi.org\/10.1097\/BRS.0b013e3181ff2cb1","journal-title":"Spine"},{"issue":"4","key":"4813_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2020.09.006","volume":"107","author":"Z Peng","year":"2021","unstructured":"Peng Z, Lin X, Kuang X, Teng Z, Lu S (2021) The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: a meta-analysis. Orthop Traumatol Surg Res 107(4):102741. https:\/\/doi.org\/10.1016\/j.otsr.2020.09.006. (PubMed PMID: 33257290)","journal-title":"Orthop Traumatol Surg Res"},{"issue":"5","key":"4813_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamasurg.2020.7259","volume":"156","author":"RV O\u2019Toole","year":"2021","unstructured":"O\u2019Toole RV, Joshi M, Carlini AR, Murray CK, Allen LE, Huang Y et al (2021) Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. JAMA Surg 156(5):1\u201312. https:\/\/doi.org\/10.1001\/jamasurg.2020.7259. (PubMed PMID: 33760010)","journal-title":"JAMA Surg"},{"issue":"11","key":"4813_CR11","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1016\/j.injury.2021.08.028","volume":"52","author":"GJ Kirchner","year":"2021","unstructured":"Kirchner GJ, Smith NP, Garner MR (2021) Intra-wound vancomycin and tobramycin powder for infection prophylaxis in orthopaedic trauma surgery: economically justifiable? Injury 52(11):3340\u20133343. https:\/\/doi.org\/10.1016\/j.injury.2021.08.028. (PubMed PMID: 34509285)","journal-title":"Injury"},{"issue":"1","key":"4813_CR12","doi-asserted-by":"publisher","first-page":"E223","DOI":"10.1097\/OI9.0000000000000223","volume":"6","author":"LS Marchand","year":"2023","unstructured":"Marchand LS, Sprague S, O\u2019Hara NN, Li CS, O\u2019Toole RV, Joshi M et al (2023) Local administration of vancomycin powder in orthopaedic fracture surgery: current practice and trends. OTA International 6(1):E223. https:\/\/doi.org\/10.1097\/OI9.0000000000000223","journal-title":"OTA International"},{"issue":"April","key":"4813_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jor.2024.03.040","volume":"55","author":"DL Lameire","year":"2024","unstructured":"Lameire DL, Soeder J, Abdel Khalik H, Pinsker E, Atri N, Khoshbin A et al (2024) Local vancomycin administration in orthopaedic surgery\u2014a systematic review of comparative studies. J Orthop 55(April):44\u201358. https:\/\/doi.org\/10.1016\/j.jor.2024.03.040","journal-title":"J Orthop"},{"issue":"10","key":"4813_CR14","doi-asserted-by":"publisher","first-page":"E400","DOI":"10.1097\/BOT.0000000000002641","volume":"37","author":"ME Awad","year":"2023","unstructured":"Awad ME, Chung JY, Griffin N, Stoneback JW, Alfonso NA (2023) Prophylactic intrawound antibiotics significantly reduce the risk of deep infections in fracture fixation: subgroup meta-analyses of the type of fracture, antibiotics, and organism. J Orthop Trauma 37(10):E400\u2013E409. https:\/\/doi.org\/10.1097\/BOT.0000000000002641","journal-title":"J Orthop Trauma"},{"key":"4813_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhin.2024.04.028","volume":"150","author":"N Saka","year":"2024","unstructured":"Saka N, Yamada K, Ono K, Iwata E, Mihara T, Uchiyama K et al (2024) Effect of topical vancomycin powder on surgical site infection prevention in major orthopaedic surgery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. J Hosp Infect 150:105\u2013113. https:\/\/doi.org\/10.1016\/j.jhin.2024.04.028","journal-title":"J Hosp Infect"},{"issue":"4","key":"4813_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/BOT.0000000000002767","volume":"38","author":"M Joshi","year":"2024","unstructured":"Joshi M, O\u2019Toole RV, Carlini AR, Gary JL, Obremskey WT, Murray CK et al (2024) Does topical vancomycin powder use in fracture surgery change bacteriology and antibiotic susceptibilities? An analysis of the VANCO trial. J Orthop Trauma 38(4):183\u2013189. https:\/\/doi.org\/10.1097\/BOT.0000000000002767","journal-title":"J Orthop Trauma"},{"key":"4813_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA et al (2020) statement: an updated guideline for reporting systematic reviews. The BMJ 2021:372. https:\/\/doi.org\/10.1136\/bmj.n71. (PubMed PMID: 33782057)","journal-title":"The BMJ"},{"key":"4813_CR18","unstructured":"RevMan 5.4.1 (2020) The Cochrane collaboration review manager. 4 (May): 1\u2013175."},{"key":"4813_CR19","volume-title":"Review of the development of the risk of bias tool for nonrandomised studies for interventions\u2014ROBINS-I","author":"M Levin","year":"2017","unstructured":"Levin M (2017) Review of the development of the risk of bias tool for nonrandomised studies for interventions\u2014ROBINS-I. Cochrane Scientific Committee"},{"key":"4813_CR20","unstructured":"Eldridge S, Campbell MK, Campbell MJ, Drahota AK, Giraudeau B, Reeves BC, et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2) Additional considerations for cluster-randomized trials (RoB 2 CRT) Cluster-randomized trials in the context of the risk of bias tool bias arising from the randomization process. 2021"},{"issue":"7650","key":"4813_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"issue":"6","key":"4813_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/BOT.0000000000002555","volume":"37","author":"N Zingas","year":"2023","unstructured":"Zingas N, Hannan ZD, Healey KM, Mckibben NS, Burke CE, Mckegg PC et al (2023) The use of vancomycin powder in tibial plateau fractures at lower risk of infection. J Orthop Trauma 37(6):282\u2013286. https:\/\/doi.org\/10.1097\/BOT.0000000000002555","journal-title":"J Orthop Trauma"},{"issue":"4","key":"4813_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10195-015-0352-0","volume":"16","author":"K Singh","year":"2015","unstructured":"Singh K, Bauer JM, LaChaud GY, Bible JE, Mir HR (2015) Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study. J Orthop Traumatol 16(4):287\u2013291. https:\/\/doi.org\/10.1007\/s10195-015-0352-0","journal-title":"J Orthop Traumatol"},{"issue":"1","key":"4813_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/BOT.0000000000001863","volume":"35","author":"R Qadir","year":"2021","unstructured":"Qadir R, Costales T, Coale M, Mulliken A, Zerhusen T, Joshi M et al (2021) Vancomycin powder use in fractures at high risk of surgical site infection. J Orthop Trauma 35(1):23\u201328. https:\/\/doi.org\/10.1097\/BOT.0000000000001863","journal-title":"J Orthop Trauma"},{"issue":"2","key":"4813_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cjtee.2023.11.006","volume":"27","author":"M Gandhi","year":"2024","unstructured":"Gandhi M, Balaji G, Menon J, Thomas RR (2024) Does topical vancomycin prevent fracture-related infections in closed fractures undergoing open reduction and internal fixation? A randomised controlled trial. Chin J Traumatol 27(2):71\u201376. https:\/\/doi.org\/10.1016\/j.cjtee.2023.11.006. (PubMed PMID: 38071168)","journal-title":"Chin J Traumatol"},{"issue":"4","key":"4813_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/BOT.0000000000001943","volume":"35","author":"KH Cichos","year":"2021","unstructured":"Cichos KH, Spitler CA, Quade JH, Ponce BA, McGwin G, Ghanem ES (2021) Intrawound antibiotic powder in acetabular fracture open reduction internal fixation does not reduce surgical site infections. J Orthop Trauma 35(4):198\u2013204. https:\/\/doi.org\/10.1097\/BOT.0000000000001943. (PubMed PMID: 32890070)","journal-title":"J Orthop Trauma"},{"issue":"7","key":"4813_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7759\/cureus.63694","volume":"16","author":"CA Acosta-Olivo","year":"2024","unstructured":"Acosta-Olivo CA, Hern\u00e1ndez-Alejo A, Rangel-Alan\u00eds AK, Elizondo-Rodr\u00edguez JA, Zertuche-Garza HM, Tamez-Mata YA et al (2024) Effect of topical vancomycin on surgical site infections in ankle fractures: a randomized, double-blind, controlled trial. Cureus 16(7):14\u201320. https:\/\/doi.org\/10.7759\/cureus.63694","journal-title":"Cureus"},{"key":"4813_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.wneu.2022.03.041","volume":"162","author":"RT Sch\u00e4r","year":"2022","unstructured":"Sch\u00e4r RT, Zimmerli S (2022) VANCO trial\u2014preliminary results on the safety profile of intrawound vancomycin powder in complex spine surgery. World Neurosurg 162:7\u20138. https:\/\/doi.org\/10.1016\/j.wneu.2022.03.041. (PubMed PMID: 35390649)","journal-title":"World Neurosurg"},{"issue":"10","key":"4813_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1530\/EOR-23-0023","volume":"9","author":"C Xie","year":"2024","unstructured":"Xie C, Zhang L, Zhang D, Tao L, Zhao Y, Luo H (2024) Efficacy and safety of vancomycin for local application in the prevention of surgical site infection after joint arthroplasty: a systematic review and meta-analysis. EFORT Open Rev 9(10):953\u2013968. https:\/\/doi.org\/10.1530\/EOR-23-0023","journal-title":"EFORT Open Rev"},{"issue":"1","key":"4813_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/JS9.0000000000001846","volume":"111","author":"B Han","year":"2025","unstructured":"Han B, Lu H, Pan A, Guan L, Cheng F, Zhao M et al (2025) Safety and efficacy of intrawound vancomycin powder in the prevention of lumbar surgical site infection: a prospective, double-blind, randomized controlled study. Int J Surg 111(1):589\u2013596. https:\/\/doi.org\/10.1097\/JS9.0000000000001846. (PubMed PMID: 38913429)","journal-title":"Int J Surg"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04813-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-026-04813-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04813-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:24:09Z","timestamp":1780730649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-026-04813-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4813"],"URL":"https:\/\/doi.org\/10.1007\/s00590-026-04813-y","relation":{},"ISSN":["1432-1068"],"issn-type":[{"value":"1432-1068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"215"}}